Portland General Electric Company (POR) Reaches $49.57 After 6.00% Up Move; Last Week BioScrip (BIOS) Coverage

November 14, 2017 - By Marie Mckinney

The stock of Portland General Electric Company (NYSE:POR) is a huge mover today! About 115,105 shares traded. Portland General Electric Company (NYSE:POR) has risen 12.10% since November 14, 2016 and is

uptrending. It has underperformed by 4.60% the S&P500.The move comes after 5 months positive chart setup for the $4.42 billion company. It was reported on Nov, 14 by Barchart.com. We have $52.54 PT which if reached, will make NYSE:POR worth $265.20 million more.

Among 6 analysts covering BioScrip (NASDAQ:BIOS), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. BioScrip had 12 analyst reports since August 11, 2015 according to SRatingsIntel. The rating was maintained by Jefferies with “Buy” on Thursday, June 8. The rating was maintained by Jefferies on Wednesday, August 9 with “Buy”. The stock of BioScrip Inc (NASDAQ:BIOS) earned “Buy” rating by Jefferies on Tuesday, July 25. The stock has “Buy” rating by SunTrust on Thursday, November 2. On Thursday, November 2 the stock rating was maintained by Jefferies with “Buy”. As per Tuesday, August 11, the company rating was downgraded by SunTrust. Lake Street initiated BioScrip Inc (NASDAQ:BIOS) on Tuesday, January 3 with “Buy” rating. The rating was upgraded by SunTrust on Thursday, August 10 to “Buy”. The firm has “Buy” rating by Dougherty & Company given on Wednesday, August 12. See BioScrip Inc (NASDAQ:BIOS) latest ratings:

02/11/2017 Broker: SunTrust Rating: Buy New Target: $3.0 Maintain
02/11/2017 Broker: Jefferies Rating: Buy New Target: $4.0 Maintain
09/08/2017 Broker: Jefferies Rating: Buy New Target: $4.0000 Maintain
10/08/2017 Broker: SunTrust Old Rating: Neutral New Rating: Buy Upgrade
25/07/2017 Broker: Jefferies Rating: Buy New Target: $3.0000 Maintain
30/06/2017 Broker: Craig Hallum Rating: Buy New Target: $3.5000
26/06/2017 Broker: Barrington Rating: Buy New Target: $3.5000
08/06/2017 Broker: Jefferies Rating: Buy New Target: $3.0000 Maintain

Analysts await Portland General Electric Company (NYSE:POR) to report earnings on February, 16. They expect $0.65 EPS, down 4.41% or $0.03 from last year’s $0.68 per share. POR’s profit will be $57.96M for 19.07 P/E if the $0.65 EPS becomes a reality. After $0.44 actual EPS reported by Portland General Electric Company for the previous quarter, Wall Street now forecasts 47.73% EPS growth.

Portland General Electric Company is an electric utility that is engaged in the wholesale purchase, transmission, distribution and retail sale of electricity in the State of Oregon. The company has market cap of $4.42 billion. The Company’s service area allocation of approximately 4,000 square miles is located entirely within Oregon and includes approximately 51 incorporated cities, of which Portland and Salem. It has a 21.46 P/E ratio. It has five natural gas-fired generating facilities, which include Port Westward Unit 1 , Port Westward Unit 2 (PW2), Beaver natural gas-fired generating plant (Beaver), Coyote Springs Unit 1 (Coyote Springs) and Carty natural gas-fired generating plant (Carty).

Among 7 analysts covering Portland General Electric (NYSE:POR), 1 have Buy rating, 4 Sell and 2 Hold. Therefore 14% are positive. Portland General Electric had 14 analyst reports since July 28, 2015 according to SRatingsIntel. JP Morgan maintained the shares of POR in report on Monday, October 30 with “Neutral” rating. As per Wednesday, August 5, the company rating was upgraded by Zacks. Goldman Sachs downgraded the stock to “Neutral” rating in Tuesday, July 28 report. The firm has “Hold” rating by KeyBanc Capital Markets given on Thursday, October 12. The firm has “Hold” rating given on Friday, August 5 by Williams Capital Group. The company was downgraded on Monday, July 24 by Williams Capital Group. Ladenburg maintained Portland General Electric Company (NYSE:POR) on Tuesday, September 19 with “Buy” rating. The stock of Portland General Electric Company (NYSE:POR) has “Underperform” rating given on Tuesday, November 22 by Bank of America. As per Monday, January 4, the company rating was downgraded by Barclays Capital. The company was downgraded on Monday, June 6 by Goldman Sachs.

Investors sentiment increased to 1.38 in 2017 Q2. Its up 0.10, from 1.28 in 2017Q1. It increased, as 20 investors sold Portland General Electric Company shares while 75 reduced holdings. 35 funds opened positions while 96 raised stakes. 82.35 million shares or 0.10% less from 82.43 million shares in 2017Q1 were reported. Frontier Capital Mngmt Com Ltd Co reported 0.62% in Portland General Electric Company (NYSE:POR). Commonwealth Equity Services Inc stated it has 0.01% of its portfolio in Portland General Electric Company (NYSE:POR). Captrust Financial Advisors owns 560 shares. New York-based Jpmorgan Chase has invested 0.05% in Portland General Electric Company (NYSE:POR). Raymond James & accumulated 0.01% or 147,681 shares. State Street has invested 0.01% in Portland General Electric Company (NYSE:POR). State Of Alaska Department Of Revenue holds 0.03% or 9,806 shares. Ferguson Wellman Cap Mngmt holds 0.01% of its portfolio in Portland General Electric Company (NYSE:POR) for 6,230 shares. 11,889 are owned by Communication Of Vermont. Teacher Retirement Sys Of Texas has invested 0.01% of its portfolio in Portland General Electric Company (NYSE:POR). Moreover, Ubs Asset Mgmt Americas has 0% invested in Portland General Electric Company (NYSE:POR). 175 were accumulated by Pittenger & Anderson. Huntington Comml Bank holds 2,809 shares or 0% of its portfolio. Deutsche Bancorporation Ag owns 171,189 shares or 0.01% of their US portfolio. 19,893 were accumulated by Ngam Advisors Ltd Partnership.

About 551,609 shares traded. BioScrip Inc (NASDAQ:BIOS) has declined 29.17% since November 14, 2016 and is downtrending. It has underperformed by 45.87% the S&P500.

BioScrip, Inc. is engaged in providing infusion solutions. The company has market cap of $281.81 million. The Firm partners with physicians, hospital systems, skilled nursing facilities, healthcare payors and pharmaceutical manufacturers to provide patients access to post-acute care services. It currently has negative earnings. The Firm operates through Infusion Services segment.

Investors sentiment increased to 1.26 in 2017 Q2. Its up 0.28, from 0.98 in 2017Q1. It improved, as 13 investors sold BioScrip Inc shares while 26 reduced holdings. 17 funds opened positions while 32 raised stakes. 103.77 million shares or 6.20% more from 97.71 million shares in 2017Q1 were reported. M&T Bancshares reported 0% in BioScrip Inc (NASDAQ:BIOS). 10,262 were reported by Proshare Advsr Limited Liability Com. 114,810 are owned by Wells Fargo And Mn. Jane Street Grp Ltd reported 0% in BioScrip Inc (NASDAQ:BIOS). Amalgamated Fincl Bank holds 0% or 14,757 shares in its portfolio. Parametric Port Associate Limited Liability Corporation holds 182,271 shares or 0% of its portfolio. Principal Financial reported 0% of its portfolio in BioScrip Inc (NASDAQ:BIOS). Coliseum Capital Mngmt Limited Liability Corp holds 9.32% or 5.62 million shares. 217,500 were accumulated by Continental Advsr Lc. Moreover, Blackstone Grp Incorporated Lp has 0% invested in BioScrip Inc (NASDAQ:BIOS). Geode Cap Management Lc reported 0% of its portfolio in BioScrip Inc (NASDAQ:BIOS). Deutsche Bancshares Ag holds 0.01% or 2.61M shares. Benchmark Capital Advsr has invested 0.31% in BioScrip Inc (NASDAQ:BIOS). Credit Suisse Ag owns 29,771 shares or 0% of their US portfolio. Massachusetts-based Camber Cap Mngmt Ltd Co has invested 1.35% in BioScrip Inc (NASDAQ:BIOS).

By

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>